Whole‐gland salvage high‐intensity focused ultrasound therapy for localized prostate cancer recurrence after external beam radiation therapy

Whole‐gland high‐intensity focused ultrasound (HIFU) has been used as salvage therapy for local recurrence following external beam radiation therapy for decades. This article describes the use of the Sonablate 500 HIFU system in the salvage setting.

[1]  Clare Allen,et al.  Accuracy of multiparametric magnetic resonance imaging in detecting recurrent prostate cancer after radiotherapy , 2010, BJU international.

[2]  M. Roach.  Primary focal unilateral nerve-sparing cryoablation for very early prostate cancer: is it enough or too much, or do we know? , 2010, Cancer journal.

[3]  V. Berge,et al.  A prospective study of salvage high-intensity focused ultrasound for locally radiorecurrent prostate cancer: Early results , 2010, Scandinavian journal of urology and nephrology.

[4]  M Emberton,et al.  Focal therapy in prostate cancer-report from a consensus panel. , 2010, Journal of endourology.

[5]  V. Mouraviev,et al.  Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy , 2010, BJU international.

[6]  R. Nigam,et al.  HIGH‐INTENSITY FOCUSED ULTRASOUND FOR LOCALIZED PROSTATE CANCER: INITIAL EXPERIENCE WITH A 2‐YEAR FOLLOW‐UP , 2009, BJU international.

[7]  T. Uchida,et al.  Transrectal high‐intensity focused ultrasound for the treatment of localized prostate cancer: Eight‐year experience , 2009, International journal of urology : official journal of the Japanese Urological Association.

[8]  C. Ogden,et al.  High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series , 2009, British Journal of Cancer.

[9]  Xianglin L. Du,et al.  Review of major adverse effects of androgen‐deprivation therapy in men with prostate cancer , 2009, Cancer.

[10]  J. Chin,et al.  Salvage HIFU for recurrent prostate cancer after radiotherapy , 2009, Prostate Cancer and Prostatic Diseases.

[11]  J. Chapelon,et al.  Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer. , 2009, European urology.

[12]  M. Schostak,et al.  Eight years' experience with high-intensity focused ultrasonography for treatment of localized prostate cancer. , 2008, Urology.

[13]  H. Ahmed,et al.  The feasibility and safety of high‐intensity focused ultrasound as salvage therapy for recurrent prostate cancer following external beam radiotherapy , 2008, BJU international.

[14]  A. D'Amico,et al.  Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate‐specific antigen failure , 2007, Cancer.

[15]  Louis Potters,et al.  Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. , 2007, International journal of radiation oncology, biology, physics.

[16]  C. Ogden,et al.  Visually directed high‐intensity focused ultrasound for organ‐confined prostate cancer: a proposed standard for the conduct of therapy , 2006, BJU international.

[17]  J. Chin,et al.  Current status of local salvage therapies following radiation failure for prostate cancer. , 2005, The Journal of urology.

[18]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[19]  L. Curiel,et al.  Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. , 2004, Urology.

[20]  Alexandra L Hanlon,et al.  Prostate cancer radiotherapy dose response: an update of the fox chase experience. , 2004, The Journal of urology.

[21]  P. Carroll,et al.  Patterns of failure after primary local therapy for prostate cancer and rationale for secondary therapy. , 2003, Urology.

[22]  D. Lubeck,et al.  Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor. , 2002, The Journal of urology.

[23]  D. Kuban,et al.  Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. , 1999, JAMA.

[24]  R H Brook,et al.  The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. , 1998, Medical care.

[25]  I. Osterloh,et al.  The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. , 1997, Urology.

[26]  C. Sherbourne,et al.  The RAND 36-Item Health Survey 1.0. , 1993, Health economics.

[27]  J. Sanabria,et al.  Proposed classification of complications of surgery with examples of utility in cholecystectomy. , 1992, Surgery.

[28]  Ján.  Treatment failure after primary and salvage therapy for prostate cancer : likelihood , patterns of care , and outcomes , 2014 .

[29]  F. Montorsi,et al.  The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer. , 2011, European urology.

[30]  P. Adamson,et al.  Patient Selection , 2002, Aesthetic Plastic Surgery.